Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lou Silverman currently holds 30,000 shares of Oncocyte Corp (OCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lou Silverman has been a net seller of OCX stock. They have purchased $12.3K and sold $11.0M worth of shares.
Lou Silverman's most recent insider trade was on Jul 1, 2024, when they sold 30,000 shares at $0.00 per share.
Lou Silverman serves as Executive at Oncocyte Corp (OCX). They have executed 57 insider transactions totaling $11.0M over their tenure at the company.
Lou Silverman holds the position of Executive at Oncocyte Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Lou Silverman has shown a selling trading pattern, with $12.3K in total purchases and $11.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lou Silverman was on Mar 1, 2021, when they sold $2.5M worth of STAA shares. This transaction involved 23,996 shares at $104.78 per share.
Lou Silverman currently owns 30,000 shares of Oncocyte Corp (OCX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lou Silverman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lou Silverman has 57 Form 4 filings on record as an insider at Oncocyte Corp.
Set alerts for Lou Silverman and 40,000+ other insiders.